-
Unlock the heartbeat code on World First Aid Day, and do so in case of cardiac arrest
Time of Update: 2021-09-19
"Save" by your side, let the light shine on everyone On this year’s World First Aid Day, Sino-Singapore’s large-scale heart health science activity "Save You", from concept creation to presentation, is conveying the precious value of life to people, "Everyone is a first aid hero" The spiritual connotation .
-
Why is it difficult to protect medical and beauty rights?
Time of Update: 2021-09-19
Li Cenyan, deputy director of the Chinese Plastic Surgery Association's Aesthetic Medicine Education and Management Branch and director of Beijing Zhijin Law Firm, told reporters that there are more chaos in medical beauty advertisements, and some medical beauty institutions are exaggerating in advertisements, which is the result of " An important reason for "appearance anxiety" .
-
Announce the list of designated medical institutions and responsible physicians for special drugs at home and abroad
Time of Update: 2021-09-19
On September 8, in order to adhere to the people's health as the center, promote the development of a multi-level medical security system, and do a good job of supporting and implementing Beijing inclusive health insurance, the Beijing Municipal Medical Insurance Bureau issued a notice on the announcement of designated medical institutions and responsible physicians for special medicines at home and abroad.
-
Domestically-made infliximab listed AID therapeutic drug market competition intensifies
Time of Update: 2021-09-19
However, most drugs that have not entered the national medical insurance catalogue are difficult to increase in volume, so AID biological preparations account for only 20% of the domestic market .
-
Scientifically reduce the use of antibiotics with high drug resistance rates to ensure the health of patients and effectively reduce medical insurance costs
Time of Update: 2021-09-18
Domestically, due to policy errors caused by misconceptions, clinical enthusiasm for the use of new anti-resistant antibiotics is low, and old antibiotics are still used in large numbers for a long time, especially foreign-funded companies have a high drug resistance rate for decades.
-
"Jiu Jiu Caring" public welfare science popularization activity to carry out Alzheimer's disease "early diagnosis and early wisdom" is imperative
Time of Update: 2021-09-18
"Long Nine Care-Charity Assistance Project for Alzheimer's Disease Patients" is sponsored by China Primary Health Care Foundation and Hongmian Public Welfare Foundation, supported by Beijing Yuanxin Technology Group and Supai Health Technology, and provided free of charge by Shanghai Green Valley Pharmaceutical Co.
-
Official: Centralized procurement of large-scale medical equipment, involving CT, MRI, etc.
Time of Update: 2021-09-13
By May of the following year, the Provincial Pharmaceutical Acquisition Center had organized a total of 15 batches of Class B large-scale medical equipment with a unit price of more than 2 million yuan.
-
Will the skyrocketing price of natural gas have a big impact on the production cost of Chinese medicinal materials?
Time of Update: 2021-09-13
At present, most of the large transactions of Chinese medicinal materials in China are carried out in the place of origin, and initial processing at the place of production has become a way for businesses to increase added value .
Affected by this, the production area has risen from 18 yuan before the new production to the current 24-26.
-
2.5 billion anti-tumor drug Shandong New Times Pharmaceutical officially enters the market
Time of Update: 2021-09-12
Figure 2: for sales of temozolomide capsules (unit: million) Source: network terminal competition pattern of China's public medical institutions on the domestic market in addition to the original research and pharmaceutical companies Merck approved imports, the Tasly, Beijing SL Pharmaceutical is also a major competition in the meter business .
-
Recruitment information is fully online, "distrust" information is fully disclosed, and completed before the end of the year
Time of Update: 2021-09-12
This notice is available to all pharmaceutical companies (especially those participating in national procurement) Directly or indirectly affects, the "Notice" mainly contains three items; Item 1: Centralized procurement of drugs and medical consumables information query (for the masses): You can query centralized procurement of drugs/medical consumables related information, such as drug medical insurance code, generic name, product name, dosage form, strength, packaging, quantity, manufacturer, approval number, hanging net price (excluding sign confidentiality agreements) and so on .
-
Listed pharmacy PK: Dashenlin is the most profitable and Yifeng has the fastest growth rate...
Time of Update: 2021-09-12
With a dense store network and a huge member community, the operating income of Lao People, Yifeng Pharmacy and Yixintang all exceeded 6 billion yuan in the first half of the year .
-
new rule!
Time of Update: 2021-09-12
According to the facts of the case as determined by court judgments or administrative penalties by relevant law enforcement agencies, in the past three years, within the province, kickbacks and other medical commercial bribery have been carried out against various medical institutions, centralized procurement institutions and their staff at all levels.
-
The number of six listed chain stores blows out!
Time of Update: 2021-09-12
Pharmaceutical retail chains represented by six listed pharmacies including Yixintang, Dashenlin, Laobaixing, Yifeng Pharmacy, Jianzhijia, and Shuyu Pingmen The sector continued its business performance in the first quarter of this year.
-
Eight departments issued documents!
Time of Update: 2021-09-12
According to the "medical community", the National Medical Insurance Administration, in conjunction with relevant departments, initially selected five cities based on scientific evaluation, focusing on pilot projects such as total volume control, price classification formation and dynamic adjustment, monitoring and evaluation, and strengthening direct contact.
-
Tonghua Dongbao stormed the 50 billion market!
Time of Update: 2021-09-12
Entering the 25 billion market On August 30, the official website of NMPA showed that Tonghua Dongbao's sitagliptin phosphate tablets were approved for listing, becoming the company's first oral hypoglycemic drug .
-
Why will Africa become the second largest market for Indian pharmaceutical companies outside the United States?
Time of Update: 2021-09-12
List of non-invested physical factories of some Indian pharmaceutical companies Data source: compiled by the official website of Indian pharmaceutical companies In addition to setting up local pharmaceutical factories and directly producing drugs, Indian companies have established a large number of branches in Africa and built a well-developed sales network.
-
The national key surveillance catalogue locks in six categories of drugs, including anticancer drugs, antibiotics, and PPI!
Time of Update: 2021-09-12
The "Regulations" pointed out that the adjustment of the national version of the key monitoring catalog includes four stages: initiation adjustment, local selection and recommendation, expert summary, and announcement of results .
-
Announcement on the inclusion of 6 substances including methyl 3-oxo-2-phenylbutyrate and 3-oxo-2-phenylbutanamide in the management of precursor chemicals
Time of Update: 2021-09-12
Methyl 3-oxo-2-phenylbutyrate , 3-oxo-2-phenylbutanamide, 2-methyl-3-[3,4-(methylenedioxy)phenyl]glycidic acid and 2-methyl-3-[3,4- (Methylenedioxy)phenyl] glycidyl methyl ester management 3-oxo-2-phenylbutyric acid methyl ester, also known as methyl α-acetyl phenylacetate, methyl α-phenylacetoacetate, referred to as MAPA , Chemical Abstracts registration number, CAS number is 16648-44-5, customs code 29183000.
-
AstraZeneca set up a new business department; influenced by the national procurement, foreign companies adjusted...
Time of Update: 2021-09-12
The fourth and fifth batches of national procurement are implemented, and many foreign enterprise promoters are affected As of today, two batches of national procurement have been launched this year.
-
Cinda's 21 Class 1 New Drugs Expose, 3 New Drugs Attack Over 26 Billion Market
Time of Update: 2021-09-12
In addition, the listing application of Sintilimab injection for second-line squamous non-small cell lung cancer is under review and is expected to be approved by the end of 2021 .
With the expansion of production capacity, the approval of new indications and the development of overseas markets, Sintilimab's sales are expected to increase .
